Current report no.: 15/2026
Date of preparation: 27 April 2026
Legal basis: Article 17(1) of the MAR Regulation – confidential
information.
In reference to current report No. 39/2025 dated December 1, 2025,
regarding the conclusion of an agreement (the “Agreement”) between
Medicalgorithmics S.A. with its registered office in Warsaw (the
“Company”, “Issuer”) and a new partner from Canada – a provider of
diagnostic and laboratory services – a publicly listed subsidiary of a
global American diagnostics company (the “Partner”), the Management
Board of Medicalgorithmics S.A. announces that on April 28, 2026, it
accepted for execution an additional order from the Partner for the
supply of Kardiobeat.ai devices. This order is to be fulfilled in 2026
and covers an increased quantity of devices sold by the Company compared
to the minimum order specified in the Agreement.
As a result of the execution of the additional order, the Company’s
anticipated remuneration from the Partner will increase relative to the
contractually guaranteed minimum revenues during the term of the
Agreement, as previously reported by the Company in current report No.
39/2025. The total value of the order received from the Partner amounts
to USD 500,000.00, i.e. approximately PLN 1,806,500.00 according to the
average exchange rate of the National Bank of Poland (NBP) as of April
27, 2026. In accordance with the provisions of the Agreement, the order
will be fulfilled following a 100% prepayment by the Partner. In
connection with the Partner’s additional order, the Issuer assumes that
the minimum remuneration from the Partner during the term of the
Agreement will amount to PLN 23,123,200.00 according to the average NBP
exchange rate as of April 27, 2026.
The Agreement is in force from the date of its conclusion (December 1,
2025) until March 31, 2028. After this period, the Agreement will be
converted into an agreement for an indefinite term and may be terminated
by either party with a 12-month notice period. In addition, the
Agreement provides for the possibility of immediate termination in the
event of a material breach by one of the parties, following a prior
unsuccessful demand to remedy the breach, as well as in the event of a
force majeure event lasting longer than the period specified in the
Agreement, but only if the Company is unable to provide any services and
fails to provide the Partner with a workable solution for the provision
of services under the Agreement within the specified timeframe.
In the opinion of the Management Board, receiving an additional order
exceeding the contracted minimum order is an important step in the
implementation of the Company’s strategy presented in current report No.
16/2023 dated June 19, 2023, which is aimed at significantly increasing
the Company’s revenues and profitability and generating positive cash
flows. In the opinion of the Company’s Management Board, the additional
order will contribute to strengthening the Company’s presence in the
North American market.
